NYSE$IQV
IQVIA Holdings Inc. · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
IQVIA delivered excellent results, with R&DS revenue on target, TAS revenue above target, margin expansion, high single-digit growth in Adjusted EPS, and outstanding free cash flow.
IQVIA reported a revenue of $3,958 million for the fourth quarter of 2024, representing a 2.3% increase on a reported basis and 3.0% at constant currency. GAAP Net Income was $437 million, with GAAP Diluted Earnings per Share at $2.42. Adjusted EBITDA was $996 million. The company reaffirms its 2025 outlook.
- Revenue for the fourth quarter was $3,958 million, up 2.3 percent on a reported basis.
- GAAP Net Income for the fourth quarter was $437 million, and GAAP Diluted Earnings per Share was $2.42.
- Adjusted EBITDA for the fourth quarter was $996 million, an increase of 3.1 percent year-over-year.
- R&D Solutions quarterly bookings of over $2.5 billion, representing a book-to-bill ratio of 1.20x.
Headline financials
Revenue & EPS history
IQVIA · Revenue · Quarterly
$3.96B
Revenue by segment
IQVIA · $3.74B total across 3 segments · Q3 2023
- Research & Development Solutions$2.12B+7.2%56.8%
- Technology & Analytics Solutions$1.43B+2.2%38.3%
- Contract Sales & Medical Solutions$183M+0.0%4.9%
Forward guidance
The company reaffirms its 2025 outlook of revenue growth at constant currency ex-COVID of 4 to 7 percent, Adjusted EBITDA margin expansion of up to 20 basis points and Adjusted Diluted Earnings per Share growth of 5 to 9 percent. These expectations result in full-year revenue guidance of $15,725 million to $16,125 million, Adjusted EBITDA of $3,765 million to $3,885 million, and Adjusted Diluted Earnings per Share of $11.70 to $12.10.
Tailwinds
- Revenue growth at constant currency ex-COVID of 4 to 7 percent.
- Adjusted EBITDA margin expansion of up to 20 basis points.
- Adjusted Diluted Earnings per Share growth of 5 to 9 percent.
- Full-year revenue guidance of $15,725 million to $16,125 million.
- Adjusted EBITDA of $3,765 million to $3,885 million.
Headwinds
- Revenue guidance assumes just over $100 million of COVID-related revenue step-down, entirely in R&DS.
- Approximately 150 basis points of headwind from foreign exchange.
- 100-150 basis points of contribution from acquisitions.
- All financial guidance assumes foreign currency exchange rates as of February 5, 2025 remain in effect for the forecast period.
- Unspecified items contained in the GAAP measures without unreasonable efforts.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+1.4%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+1.9%
Avg return
30 days after
65%
37 / 57 earnings
Positive
+12.5%
Q2 2018
Best reaction
-10.7%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +7.7% | +10.9% | +13.9% | |
| Q4 2025 | -10.7% | -9.9% | -13.8% | |
| Q3 2025 | +0.3% | -0.4% | +6.6% | |
| Q2 2025 | -0.4% | +1.1% | -1.6% | |
| Q1 2025 | -4.0% | -2.2% | -3.2% | |
| Q4 2024 | +2.2% | -2.2% | -6.7% | |
| Q3 2024 | -3.2% | -1.5% | -7.0% | |
| Q2 2024 | +6.3% | +6.7% | +10.0% | |
| Q1 2024 | -4.1% | -1.6% | -5.9% | |
| Q4 2023 | +12.2% | +10.8% | +17.4% | |
| Q3 2023 | +5.3% | +9.7% | +20.0% | |
| Q2 2023 | -2.1% | -3.1% | -0.5% | |
| Q1 2023 | -0.9% | -2.3% | +5.0% | |
| Q4 2022 | +0.8% | -1.4% | -14.4% | |
| Q3 2022 | +1.4% | +6.1% | +11.3% | |
| Q2 2022 | +0.5% | -0.4% | +8.3% | |
| Q1 2022 | +6.1% | +5.0% | +6.7% | |
| Q4 2021 | -3.2% | -4.8% | -6.9% | |
| Q3 2021 | +2.1% | +1.8% | +6.6% | |
| Q2 2021 | -0.8% | +0.2% | +4.5% | |
| Q1 2021 | +6.1% | +7.0% | +9.1% | |
| Q4 2020 | +4.9% | +4.8% | +1.6% | |
| Q3 2020 | +3.2% | +2.1% | +3.4% | |
| Q2 2020 | +2.9% | +3.4% | +0.4% | |
| Q1 2020 | +8.5% | +3.5% | +10.9% | |
| Q4 2019 | +2.5% | +1.6% | -26.6% | |
| Q3 2019 | -3.8% | -2.4% | -2.7% | |
| Q2 2019 | +2.1% | +1.6% | -2.3% | |
| Q1 2019 | -2.0% | -0.1% | -2.2% | |
| Q4 2018 | +7.6% | +7.3% | +7.4% | |
| Q3 2018 | -3.5% | -5.3% | -8.4% | |
| Q2 2018 | +12.5% | +8.2% | +11.7% | |
| Q1 2018 | -0.7% | +0.2% | +2.6% | |
| Q4 2017 | +1.5% | +1.7% | +5.6% | |
| Q3 2017 | +6.1% | +6.5% | +2.7% | |
| Q2 2017 | -1.3% | -1.0% | +4.4% | |
| Q1 2017 | -3.7% | -2.0% | +3.0% | |
| Q4 2016 | -2.7% | -4.1% | +0.5% | |
| Q3 2016 | +0.8% | +4.1% | +3.3% | |
| Q2 2016 | +3.3% | +4.2% | +0.3% | |
| Q1 2016 | -5.9% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -6.2% | — | — | |
| Q2 2015 | +2.6% | — | — | |
| Q1 2015 | -4.9% | — | — | |
| Q4 2014 | +4.3% | — | — | |
| Q3 2014 | +0.9% | — | — | |
| Q2 2014 | -3.1% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2011 | +7.5% | — | — | |
| Q4 2013 | +7.5% | — | — | |
| Q3 2012 | +0.1% | — | — | |
| Q3 2013 | +0.1% | — | — | |
| Q2 2012 | +0.8% | — | — | |
| Q2 2013 | +0.8% | — | — | |
| Q1 2012 | +5.0% | — | — | |
| Q4 2012 | +5.0% | — | — | |
| Q1 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro